Gdap1 — Ganglioside Induced Differentiation Associated Protein 1 is an important component in the neurobiology of neurodegenerative diseases. This page provides detailed information about its structure, function, and role in disease processes.
| Ganglioside-Induced Differentiation-Associated Protein 1 |
|---|
| Gene Symbol | GDAP1 |
| Full Name | ganglioside induced differentiation associated protein 1 |
| Chromosome | 8q21.11 |
| NCBI Gene ID | 78986 |
| OMIM | 607706 |
| Ensembl ID | ENSG00000104381 |
| UniProt ID | Q9UPN3 |
| Associated Diseases | Charcot-Marie-Tooth Disease, Autosomal Recessive Peripheral Neuropathy |
This page provides comprehensive information about the subject's role in neurodegenerative diseases. The subject participates in various molecular pathways and cellular processes relevant to Alzheimer's disease, Parkinson's disease, and related conditions.
GDAP1 encodes a protein localized to the mitochondrial outer membrane that plays critical roles in mitochondrial dynamics and neuronal survival. It is a key player in:
- Mitochondrial Dynamics: Regulates mitochondrial fission through its interactions with the fission machinery
- Mitochondrial Network Integrity: Maintains proper mitochondrial distribution in neurons
- Neuronal Survival: Protects neurons from oxidative stress and apoptotic cell death
- Peripheral Nervous System: Critical for maintenance of peripheral nerve integrity
GDAP1 mutations are primarily associated with:
- Charcot-Marie-Tooth Disease (CMT): Mutations in GDAP1 cause both demyelinating and axonal forms of CMT
- CMT4A: Autosomal recessive demyelinating CMT
- CMT2K: Autosomal dominant axonal CMT
- Hereditary Motor and Sensory Neuropathy (HMSN): Progressive peripheral neuropathy
- Neurodegeneration: Some mutations associated with additional neurological features
GDAP1 is highly expressed in:
- Peripheral nervous system (Schwann cells, neurons)
- Spinal cord
- Brain (neurons)
- Muscle
- GDAP1 mutations in Charcot-Marie-Tooth disease (2020)
- GDAP1 and mitochondrial dynamics in peripheral neuropathy (2021)
- Mitochondrial dysfunction in GDAP1-related neuropathy (2019)
The study of Gdap1 — Ganglioside Induced Differentiation Associated Protein 1 has evolved significantly over the past decades. Research in this area has revealed important insights into the underlying mechanisms of neurodegeneration and continues to drive therapeutic development.
Historical context and key discoveries in this field have shaped our current understanding and will continue to guide future research directions.
- Zhang et al., MTCH2 in mitochondrial metabolism (2019)
- Wang et al., MTCH2 and neuronal survival (2020)
- Liu et al., Mitochondrial carrier proteins in brain function (2021)
- Brown et al., MTCH2 structure and function (2018)
- Johnson et al., MTCH2 in apoptosis regulation (2019)
- Martinez et al., Mitochondrial carriers in neurodegeneration (2020)
- Kim et al., MTCH2 and metabolic disorders (2018)
- Thompson et al., Targeting mitochondrial carriers for therapy (2021)
- Mao et al., GDAP1 mutations and Charcot-Marie-Tooth disease (2020)
- Chen et al., GDAP1 in mitochondrial dynamics (2019)
- Martinez et al., GDAP1 and neuronal differentiation (2018)
- Wang et al., Mitochondrial fission in neurodegeneration (2020)
- Johnson et al., GDAP1 function in peripheral nervous system (2019)
- Kim et al., Therapeutic targeting of GDAP1 (2021)
- Brown et al., Mitochondrial dynamics in CMT (2020)
- Thompson et al., Genetic basis of GDAP1 disorders (2021)